What's hot
View all perspectives
Dr. John Cush RheumNow
1 year 4 months ago
Is there an Increasing Risk for Tick-Borne Disease ? JAMA article purports this to be so..... I think not - not unless you live in endemic areas. Other wise these still are rare, rare or misdiagnosis based on serologic inaccuracies - just my opinion.https://t.co/Sfu2UlLlwH https://t.co/z5TpNrDCWD
Dr. John Cush RheumNow
1 year 4 months ago
Intl Consensus: Generalized Pustular Psoriasis... systemic inflammatory disease characterized by cutaneous erythema and ...sterile pustules.” ...with or without systemic symptoms. GPP may (b) acute... w/ widespread pustules or subacute w/ annular phenotype https://t.co/dsKsQQYyj4 https://t.co/FVoTaw7mPl
Dr. Jack Cush reviews FDA approval, news and journal articles -- and it’s the week before EULAR 2024 in Vienna!!
Dr. John Cush RheumNow
1 year 4 months ago
JAK or TNF Inhibitor as First Drug for Rheumatoid Arthritis?
A JAK inhibitor outperformed TNF blockers for substantially reducing RA symptoms in patients for whom conventional anti-rheumatic drugs had failed, a pragmatic head-to-head trial found.
https://t.co/7BhFSwb1Ns https://t.co/Hf31OPgE0M
Dr. John Cush RheumNow
1 year 4 months ago
2023 EULAR classification criteria for hand osteoarthritis
A EULAR consensus group has established classification criteria for overall hand osteoarthritis (OA) and its subtypes (interphalangeal OA and thumb base OA).
https://t.co/r7hR1rkjb7 https://t.co/IBC0BpNlW8
Dr. John Cush RheumNow
1 year 4 months ago
ACR Calls on CMS for Enhanced Transparency & Reporting
The ACR has submitted its response to the CMS)request for information (RFI) and feedback from stakeholders on how best to enhance MA data capabilities and increase public transparency.
https://t.co/vWPXlhmUGo https://t.co/Z8s3PZijqE
Poster Hall